+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Rat Model Market (2023-2028) by Clinical Trials & Research, Model Type, Service, Technology, Therapeutic Area, Geography, Competitive Analysis, and Impact of Covid-19, Ansoff Analysis

  • PDF Icon

    Report

  • 179 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5601387
The Global Rat Model Market is estimated to be USD 697.62 Mn in 2023 and is expected to reach USD 1016.04 Mn by 2028 growing at a CAGR of 7.81%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the Global Rat Model Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Rat Model Market is segmented based on Clinical Trials & Research, Model Type, Service, Technology, Therapeutic Area, and Geography.
  • By Clinical Trials & Research, the market is classified into Clinical Trials, and Research Studies.
  • By Model Type, the market is classified into Outbred Rats, Inbred Rats, Knockout/Genetically Engineered Rats, Hybrid/Congenic Rats, Conditioned/Surgically Modified Rats, and Immunodeficient Rats.
  • By Service, the market is classified into Breeding, Cryopreservation, Quarantine, Rederivation, Model In-Licensing, Genetic Testing, and Others.
  • By Technology, the market is classified into Crispr, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, and Other Technologies.
  • By Therapeutic Area, the market is classified into Toxicology, Oncology, Immunology and Inflammation, Neurology, Diabetes, and Others.
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Charles River Laboratories International, Taconic Biosciences, Envigo, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Rat Model Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Rat Model Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Rat Model Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Advancements in Gene Editing Tools Set to Augment the Demand for Rat Models
4.1.2 Advantages Offered by Rats Over Mice
4.1.3 Continuous Support in the form of Investments and Grants
4.1.4 Increased Demand for Personalized Humanized Rat Models due to Growing Consumption of Personalized Medicines
4.1.5 Increase in R&D Activities Carried Out by Pharmaceutical and Biotechnology Companies
4.2 Restraints
4.2.1 Regulations & Laws Formulated for Ethical use of Animals
4.2.2 Increased Benefits Offered by Cryopreservation
4.3 Opportunities
4.3.1 Increased Production of Monoclonal Antibodies
4.3.2 Increasing Demand of Humanized Rat Models
4.4 Challenges
4.4.1 Advancements in Zebrafish Model Development
4.4.2 Development of Methods Alternative to Animal Testing
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Rat Model Market, By Clinical Trials & Research
6.1 Introduction
6.2 Clinical Trials
6.3 Research Studies
7 Global Rat Model Market, By Model Type
7.1 Introduction
7.2 Outbred Rats
7.3 Inbred Rats
7.4 Knockout/Genetically Engineered Rats
7.5 Hybrid/Congenic Rats
7.6 Conditioned/Surgically Modified Rats
7.7 Immunodeficient Rats
8 Global Rat Model Market, By Service
8.1 Introduction
8.2 Breeding
8.3 Cryopreservation
8.4 Quarantine
8.5 Rederivation
8.6 Model In-Licensing
8.7 Genetic Testing
8.8 Others
8.8.1 Surgical Services
8.8.2 Line Rescue Services
8.8.3 In Vivo Pharmacology Services
9 Global Rat Model Market, By Technology
9.1 Introduction
9.2 Crispr
9.3 Microinjection
9.4 Embryonic Stem Cell Injection
9.5 Nuclear Transfer
9.6 Other Technologies
10 Global Rat Model Market, By Therapeutic Area
10.1 Introduction
10.2 Toxicology
10.3 Oncology
10.4 Immunology and Inflammation
10.5 Neurology
10.6 Diabetes
10.7 Others
11 Americas’ Rat Model Market
11.1 Introduction
11.2 Argentina
11.3 Brazil
11.4 Canada
11.5 Chile
11.6 Colombia
11.7 Mexico
11.8 Peru
11.9 United States
11.10 Rest of Americas
12 Europe’s Rat Model Market
12.1 Introduction
12.2 Austria
12.3 Belgium
12.4 Denmark
12.5 Finland
12.6 France
12.7 Germany
12.8 Italy
12.9 Netherlands
12.10 Norway
12.11 Poland
12.12 Russia
12.13 Spain
12.14 Sweden
12.15 Switzerland
12.16 United Kingdom
12.17 Rest of Europe
13 Middle East and Africa’s Rat Model Market
13.1 Introduction
13.2 Egypt
13.3 Israel
13.4 Qatar
13.5 Saudi Arabia
13.6 South Africa
13.7 United Arab Emirates
13.8 Rest of MEA
14 APAC’s Rat Model Market
14.1 Introduction
14.2 Australia
14.3 Bangladesh
14.4 China
14.5 India
14.6 Indonesia
14.7 Japan
14.8 Malaysia
14.9 Philippines
14.10 Singapore
14.11 South Korea
14.12 Sri Lanka
14.13 Thailand
14.14 Taiwan
14.15 Rest of Asia-Pacific
15 Competitive Landscape
15.1 Competitive Quadrant
15.2 Market Share Analysis
15.3 Strategic Initiatives
15.3.1 M&A and Investments
15.3.2 Partnerships and Collaborations
15.3.3 Product Developments and Improvements
16 Company Profiles
16.1 Charles River Laboratories International
16.2 Taconic Biosciences
16.3 Envigo
16.4 Lab Drug Development
16.5 Janvier Labs
16.6 Genoway
16.7 Biomere
16.8 Horizon Discovery
16.9 Transviragen
17 Appendix
17.1 Questionnaire

Companies Mentioned

  • Charles River Laboratories International
  • Taconic Biosciences
  • Envigo
  • Lab Drug Development
  • Janvier Labs
  • Genoway
  • Biomere
  • Horizon Discovery
  • Transviragen